Promises of a biocompatible nanocarrier in improved brain delivery of quercetin: Biochemical, pharmacokinetic and biodistribution evidences
- 1 December 2016
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 515 (1-2) , 307-314
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Stability and Biological Activity Evaluation of Chlorantraniliprole Solid Nanodispersions Prepared by High Pressure HomogenizationPLOS ONE, 2016
- Quercetin/β-cyclodextrin inclusion complex embedded nanofibres: Slow release and high solubilityFood Chemistry, 2016
- Positively charged self-nanoemulsifying oily formulations of olmesartan medoxomil: Systematic development, in vitro, ex vivo and in vivo evaluationInternational Journal of Pharmaceutics, 2015
- Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticlesJournal of Controlled Release, 2013
- Review on in vivo and in vitro methods evaluation of antioxidant activitySaudi Pharmaceutical Journal, 2013
- Development of a Quercetin-loaded nanostructured lipid carrier formulation for topical deliveryInternational Journal of Pharmaceutics, 2012
- Formulation development and systematic optimization of solid lipid nanoparticles of quercetin for improved brain deliveryJournal of Pharmacy and Pharmacology, 2011
- Effect of Poly(N-vinyl-pyrrolidone)-block-poly(d,l-lactide) as Coating Agent on the Opsonization, Phagocytosis, and Pharmacokinetics of Biodegradable NanoparticlesBiomacromolecules, 2009
- Vitamin E deficiency induced neurological disease in common variable immunodeficiency: two cases and a review of the literature of vitamin E deficiencyClinical Immunology, 2004
- Oxidative Nerve Cell Death in Alzheimers Disease and Stroke: Antioxidants as Neuroprotective CompoundsBiological Chemistry, 2002